Category: Patient assistance

According to the National Institute on Drug Abuse, Medication-Assisted Treatment (MAT) for opioid use disorder is often highly effective but can be costly. The Suboxone discount program, offered by the manufacturer via the INSUPPORT® program, provides financial assistance to eligible patients to help reduce these costs and improve access to treatment. This article will delve into the specifics of this program and other potential savings options.

With a list price often exceeding $1,000 per month, Mounjaro can be prohibitively expensive without assistance. The manufacturer, Eli Lilly, offers a Mounjaro coupon (or savings card) that can significantly lower costs for eligible patients. Understanding the specific requirements is crucial to determine who qualifies for the Mounjaro coupon, which is not available to everyone.

With annual costs for nitisinone treatment potentially running into the hundreds of thousands of dollars, managing the financial aspect of this rare disease medication is a significant concern for patients. This article explores the factors influencing how much does nitisinone cost and outlines the various pathways for financial relief.